Acadia Pharmaceuticals (ACAD) shares rose 1.5% in recent Monday trading after Mizuho upgraded the company's stock to outperform from neutral and raised the price target to $35 from $29.
Trading volume stood at over 1.2 million shares compared with a daily average of about 1.4 million shares.
Price: 24.37, Change: +0.38, Percent Change: +1.58